Type I Diabetes—A Rare Adverse Event Described in Patients Receiving Immunotherapy Versus a Side Effect from SARS-CoV-2 Infection

Type I Diabetes—A Rare Adverse Event Described in Patients Receiving Immunotherapy Versus a Side Effect from SARS-CoV-2 Infection

<b>Background and Clinical Significance</b>: Lung cancer, a leading cause of global cancer diagnoses, maintains the highest mortality risk despite advances in treatment. Immunotherapy agents, such as anti-programmed death-1/programmed death ligand-1 (PD-1/PD-L1), have revolutionized care...

Full description

Saved in:
Bibliographic Details
Main Authors: Raluca-Ileana Pătru, Miruna Ghigeanu, Maria-Alexandra Barbu, Andreea Iuliana Ionescu, Antone-Iordache Ionuț-Lucian
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Reports
Subjects:
lung cancer
immunotherapy
type I diabetes
adverse effect
SARS-CoV-2 pandemic
Online Access:https://www.mdpi.com/2571-841X/8/1/31
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items